Sudhir Bassi, Thomas George 
Dealstreet

Khaitan & Co advises Capillary Tech on DRHP filing

The IPO comprises a fresh issue aggregating up to ₹430 crore and an offer for sale of up to 18,331,386 equity shares.

Bar & Bench

Khaitan & Co advised Capillary Technologies India Limited and its Promoter Selling Shareholder, Capillary Technologies International Pte. Ltd., on the filing of the draft red herring prospectus for the company’s proposed initial public offering (IPO).

The IPO comprises a fresh issue of equity shares aggregating up to ₹430 crore and an offer for sale of up to 18,331,386 equity shares of face value ₹2 each.

The transaction team consisted of Sudhir Bassi (Executive Director - Capital Markets), Thomas George (Partner), Poorvi M Jain (Principal Associate), Jash Botadra (Associate), Sanjeev Ramakrishnan (Associate), Anand Sivasankaran (Associate).

Proceeds from the fresh issue are earmarked primarily for cloud infrastructure (₹120 cr), product R&D (₹151.54 cr), purchase of computer systems (₹10.32 cr), with the remainder reserved for potential acquisitions and general corporate purposes.

The IPO is being managed by JM Financial, IIFL Capital, and Nomura, and marks Capillary’s second attempt to go public, having shelved an earlier plan in 2021

Founded in 2012, Capillary Technologies offers a comprehensive suite of solutions designed to help businesses boost customer retention, engagement, and revenue. Their platform provides a unified view of customers across all channels, enabling brands to deliver personalized experiences and build stronger relationships.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Interpol arrest warrant cannot be ignored merely because there is no extradition request: Kerala High Court

What if cash was found in a minister’s house? Harish Salve questions handling of Justice Yashwant Varma episode

J&K Advocate General's post vacant since October 2024; PIL in High Court seeks appointment

Shardul Amarchand Mangaldas & Co elevates 7 Partners to Equity Partnership

Delhi HC rejects Vimal Elaichi's plea against Maharashtra FDA notice to Shah Rukh Khan, Ajay Devgn, Tiger Shroff

SCROLL FOR NEXT